Capacity Bio is a clinical-stage biotechnology company developing mitophagy therapeutics to restore mitochondrial quality control in age- and disease-related conditions. Its platform advances small molecules, peptides, and nanoparticles that enhance identification and clearance of dysfunctional mitochondria.
company biotechnology drug-development apis-json therapeutics mitochondrial-biology biotech-therapeutics mitophagy
-
Updated
Aug 4, 2026